Literature DB >> 9730688

Role of the brain in interleukin-6 modulation.

L Terreni1, M G De Simoni.   

Abstract

High levels of interleukin 6 (IL-6) have been found in the brain tissue or cerebrospinal fluid (CSF) in several CNS disorders including Alzheimer's disease, AIDS dementia complex, multiple sclerois, stroke, Parkinson's disease, traumatic brain injuries, brain tumors and CNS infections. In these diseases, IL-6 is also found in blood showing that CNS conditions can elicit a peripheral immune response. A direct secretion of IL-6 from brain to blood has been shown to be a major mechanism by which the brain activates peripheral metabolic, endocrine and immune responses. However, this communication is not straightforward and other regulatory mechanisms are likely to be there. Several lines of evidence obtained in the laboratory have shown that the brain significantly modulates IL-6 production in the periphery. Evidence will be given that: (i) central inflammatory stimuli efficiently induce peripheral IL-6; (ii) central opioids are effective modulators of peripheral IL-6, and (iii) the sympathetic nervous system represents an inhibitory pathway to peripheral IL-6.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730688     DOI: 10.1159/000026339

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  7 in total

1.  Neuropil pruning in Early-Course Schizophrenia: Immunological, Clinical, and Neurocognitive Correlates.

Authors:  Konasale M Prasad; Ashley M Burgess; Matcheri S Keshavan; Vishwajit L Nimgaonkar; Jeffrey A Stanley
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-11

2.  Central injection of nitric oxide synthase inhibitors increases peripheral interleukin-6 and serum amyloid A: involvement of adrenaline from adrenal medulla.

Authors:  D K Song; Y B Im; J S Jung; J J Yan; S O Huh; H W Suh; Y H Kim
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  IL-6 regulation of synaptic function in the CNS.

Authors:  Donna L Gruol
Journal:  Neuropharmacology       Date:  2014-11-22       Impact factor: 5.250

4.  Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors.

Authors:  Vassilis Samaras; Christina Piperi; Penelope Korkolopoulou; Athanasios Zisakis; Georgia Levidou; Marios S Themistocleous; Efstathios I Boviatsis; Damianos E Sakas; Robert W Lea; Anastasios Kalofoutis; Efstratios Patsouris
Journal:  Mol Cell Biochem       Date:  2007-06-06       Impact factor: 3.396

5.  Glimepiride reduces CD14 expression and cytokine secretion from macrophages.

Authors:  Victoria Ingham; Alun Williams; Clive Bate
Journal:  J Neuroinflammation       Date:  2014-06-21       Impact factor: 8.322

6.  Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease.

Authors:  Sebastiano Gangemi; Giorgio Basile; Rosaria Alba Merendino; Antonio Epifanio; Giuseppe Di Pasquale; Benito Ferlazzo; Vittorio Nicita-Mauro; Letterio Morgante
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

7.  Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.

Authors:  Andrew Schrepf; Lauren Clevenger; Desire Christensen; Koen DeGeest; David Bender; Amina Ahmed; Michael J Goodheart; Laila Dahmoush; Frank Penedo; Joseph A Lucci; Parvin Ganjei-Azar; Luis Mendez; Kristian Markon; David M Lubaroff; Premal H Thaker; George M Slavich; Anil K Sood; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2012-08-05       Impact factor: 7.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.